Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study. Kubota, K., Hida, T., Ishikura, S., Mizusawa, J., Nishio, M., Kawahara, M., Yokoyama, A., Imamura, F., Takeda, K., Negoro, S., & others The Lancet Oncology, 15(1):106–113, 2014.
Paper bibtex @article{kubota_etoposide_2014,
title = {Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy ({JCOG0202}): a randomised phase 3 study},
volume = {15},
shorttitle = {Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy ({JCOG0202})},
url = {http://www.sciencedirect.com/science/article/pii/S1470204513705114},
number = {1},
urldate = {2017-05-22},
journal = {The Lancet Oncology},
author = {Kubota, Kaoru and Hida, Toyoaki and Ishikura, Satoshi and Mizusawa, Junki and Nishio, Makoto and Kawahara, Masaaki and Yokoyama, Akira and Imamura, Fumio and Takeda, Koji and Negoro, Shunichi and {others}},
year = {2014},
pages = {106--113},
}
Downloads: 0
{"_id":"moQk8fRqzb8iu9amE","bibbaseid":"kubota-hida-ishikura-mizusawa-nishio-kawahara-yokoyama-imamura-etal-etoposideandcisplatinversusirinotecanandcisplatininpatientswithlimitedstagesmallcelllungcancertreatedwithetoposideandcisplatinplusconcurrentacceleratedhyperfractionatedthoracicradiotherapyjcog0202arandomisedphase3study-2014","author_short":["Kubota, K.","Hida, T.","Ishikura, S.","Mizusawa, J.","Nishio, M.","Kawahara, M.","Yokoyama, A.","Imamura, F.","Takeda, K.","Negoro, S.","others"],"bibdata":{"bibtype":"article","type":"article","title":"Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study","volume":"15","shorttitle":"Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202)","url":"http://www.sciencedirect.com/science/article/pii/S1470204513705114","number":"1","urldate":"2017-05-22","journal":"The Lancet Oncology","author":[{"propositions":[],"lastnames":["Kubota"],"firstnames":["Kaoru"],"suffixes":[]},{"propositions":[],"lastnames":["Hida"],"firstnames":["Toyoaki"],"suffixes":[]},{"propositions":[],"lastnames":["Ishikura"],"firstnames":["Satoshi"],"suffixes":[]},{"propositions":[],"lastnames":["Mizusawa"],"firstnames":["Junki"],"suffixes":[]},{"propositions":[],"lastnames":["Nishio"],"firstnames":["Makoto"],"suffixes":[]},{"propositions":[],"lastnames":["Kawahara"],"firstnames":["Masaaki"],"suffixes":[]},{"propositions":[],"lastnames":["Yokoyama"],"firstnames":["Akira"],"suffixes":[]},{"propositions":[],"lastnames":["Imamura"],"firstnames":["Fumio"],"suffixes":[]},{"propositions":[],"lastnames":["Takeda"],"firstnames":["Koji"],"suffixes":[]},{"propositions":[],"lastnames":["Negoro"],"firstnames":["Shunichi"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["others"],"suffixes":[]}],"year":"2014","pages":"106–113","bibtex":"@article{kubota_etoposide_2014,\n\ttitle = {Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy ({JCOG0202}): a randomised phase 3 study},\n\tvolume = {15},\n\tshorttitle = {Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy ({JCOG0202})},\n\turl = {http://www.sciencedirect.com/science/article/pii/S1470204513705114},\n\tnumber = {1},\n\turldate = {2017-05-22},\n\tjournal = {The Lancet Oncology},\n\tauthor = {Kubota, Kaoru and Hida, Toyoaki and Ishikura, Satoshi and Mizusawa, Junki and Nishio, Makoto and Kawahara, Masaaki and Yokoyama, Akira and Imamura, Fumio and Takeda, Koji and Negoro, Shunichi and {others}},\n\tyear = {2014},\n\tpages = {106--113},\n}\n\n","author_short":["Kubota, K.","Hida, T.","Ishikura, S.","Mizusawa, J.","Nishio, M.","Kawahara, M.","Yokoyama, A.","Imamura, F.","Takeda, K.","Negoro, S.","others"],"key":"kubota_etoposide_2014","id":"kubota_etoposide_2014","bibbaseid":"kubota-hida-ishikura-mizusawa-nishio-kawahara-yokoyama-imamura-etal-etoposideandcisplatinversusirinotecanandcisplatininpatientswithlimitedstagesmallcelllungcancertreatedwithetoposideandcisplatinplusconcurrentacceleratedhyperfractionatedthoracicradiotherapyjcog0202arandomisedphase3study-2014","role":"author","urls":{"Paper":"http://www.sciencedirect.com/science/article/pii/S1470204513705114"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/zotero/tplas","dataSources":["YLgywGcXWx96vKKaB"],"keywords":[],"search_terms":["etoposide","cisplatin","versus","irinotecan","cisplatin","patients","limited","stage","small","cell","lung","cancer","treated","etoposide","cisplatin","plus","concurrent","accelerated","hyperfractionated","thoracic","radiotherapy","jcog0202","randomised","phase","study","kubota","hida","ishikura","mizusawa","nishio","kawahara","yokoyama","imamura","takeda","negoro","others"],"title":"Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study","year":2014}